DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7nfx8d/duchenne_muscular) has announced the addition of the "Duchenne Muscular Dystrophy - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic development for Duchenne Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Duchenne Muscular Dystrophy and special features on late-stage and discontinued projects.
Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
- Eli Lilly and Company
- Daiichi Sankyo Company, Limited
- Nippon Shinyaku Co., Ltd.
- Sarepta Therapeutics, Inc.
- NicOx S.A.
- Galapagos NV
- Summit Corporation plc
- Santhera Pharmaceuticals Holding AG
- Shenzhen Beike Biotechnology Co., Ltd.
- Italfarmaco S.p.A.
- Prosensa Holding BV
- Catabasis Pharmaceuticals, Inc.
- Nobelpharma Co., Ltd.
- PTC Therapeutics, Inc.
- Fate Therapeutics, Inc.
- N-Gene Research Laboratories, Inc.
- Asklepios BioPharmaceutical, Inc.
- miRagen Therapeutics, Inc.
- Prosensa Therapeutics B.V.
- EryDel SPA
- Myomics, Inc.
- Prothelia, Inc.
- ReveraGen BioPharma, Inc.
- Retrophin, LLC
For more information visit http://www.researchandmarkets.com/research/7nfx8d/duchenne_muscular